IDYA · NASDAQ · Biotechnology

IDEAYA Biosciences

Develops biomarker-selected cancer drugs across small molecules and antibody-drug conjugates.

$40.11
After-hours close−0.02 (−0.05%)
At close$40.13(−3.93%)

Breakdown13F · Form 4

Institutions 111.92%Insiders 0.09%

A 13F quarter can total more than the shares outstanding — sub-advisers file the same block twice, and a filer's own share count can be a quarter stale. No split is drawn from it.

Shares outstanding 95.08M · Float 87.08M · 91.6% free float

Top shareholders13F · 13D/G · Form 4

HolderShares% outstandingFormFiled
FMR LLC14.11M14.84%13FAug 13, 2026
BlackRock, Inc.8.89M9.35%13FAug 7, 2026
Jupiter Topco LLC8.58M9.02%13FAug 14, 2026
Janus Henderson Group PLC7.27M8.30%13GMay 15, 2026
Capital Research Global Investors5.34M5.62%13FAug 12, 2026

Institutions13F, as of Jun 30, 2026

292 holders · 106.41M shares · 67 new positions · 159 increased · 90 reduced · 36 closed

HolderShares% outstandingChg q/qFiled
FMR LLC14.11M14.84%+937.3KAug 13, 2026
BlackRock, Inc.8.89M9.35%+451.1KAug 7, 2026
Jupiter Topco LLC8.58M9.02%+8.58MnewAug 14, 2026
Capital Research Global Investors5.34M5.62%+181.2KAug 12, 2026
Baker Bros. Advisors LP5.01M5.27%+1.06MAug 14, 2026
State Street Corp4.55M4.78%+767.7KAug 7, 2026
Vanguard Capital Management LLC4.13M4.35%+400.2KAug 13, 2026
Logos Global Management LP3.00M3.16%−450.0KAug 14, 2026

Beneficial owners13D/G · 5% or more, as filed

Holder% of classSharesFormFiled
Janus Henderson Group PLC8.30%7.27M13GMay 15, 2026
BlackRock, Inc.8.10%7.13M13GApr 17, 2025
Capital Research Global Investors6.00%5.28M13GFeb 12, 2026
Baker Bros. Advisors LP5.20%5.01M13GAug 14, 2026
Vanguard Capital Management5.08%4.83M13GJul 31, 2026

InsidersForm 4

InsiderRoleShares% outstandingFiled
Jeffrey Steindirector54.3K0.06%Mar 2, 2026
Briseno Andres Ruizofficer: Chief Accounting Officer26.5K0.03%Jul 9, 2026
Douglas B. Snyderofficer: SVP, General Counsel2.1K0.00%Feb 2, 2026

4 ten-percent owners hold 2.36M shares by Form 4, outside the officers-and-directors figure above · 8 people have not refiled in the last 18 months (2.68M shares), so they are not in the figure above

Latest trades

DateInsiderTypeSharesAvg priceOwned after
Jul 7, 2026
Briseno Andres Ruizofficer: Chief Accounting Officer
Sale9,550$40.0126,466
Mar 2, 2026
Jeffrey Steindirector
Purchase50,000$32.9654,281

CongressHouse and Senate disclosures

Not reported.